ArticleTranslational lung cancer research2022

Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO.

Christian Grohé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.